Cargando…
Torulene and torularhodin: “new” fungal carotenoids for industry?
Torulene and torularhodin represent the group of carotenoids and are synthesized by yeasts and fungi. The most important producers of these two compounds include yeasts of Rhodotorula and Sporobolomyces genera. The first reports confirming the presence of torulene and torularhodin in the cells of mi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870927/ https://www.ncbi.nlm.nih.gov/pubmed/29587755 http://dx.doi.org/10.1186/s12934-018-0893-z |
_version_ | 1783309565098459136 |
---|---|
author | Kot, Anna M. Błażejak, Stanisław Gientka, Iwona Kieliszek, Marek Bryś, Joanna |
author_facet | Kot, Anna M. Błażejak, Stanisław Gientka, Iwona Kieliszek, Marek Bryś, Joanna |
author_sort | Kot, Anna M. |
collection | PubMed |
description | Torulene and torularhodin represent the group of carotenoids and are synthesized by yeasts and fungi. The most important producers of these two compounds include yeasts of Rhodotorula and Sporobolomyces genera. The first reports confirming the presence of torulene and torularhodin in the cells of microorganisms date to the 1930s and 1940s; however, only in the past few years, the number of works describing the properties of these compounds increased. These compounds have strong anti-oxidative and anti-microbial properties, and thus may be successfully used as food, feedstock, and cosmetics additives. In addition, tests performed on rats and mice showed that both torulene and torularhodin have anti-cancerous properties. In order to commercialize the production of these two carotenoids, it is necessary to obtain highly efficient yeast strains, for example, via mutagenization and optimization of cultivation conditions. Further studies on the activity of torulene and torularhodin on the human body are also needed. |
format | Online Article Text |
id | pubmed-5870927 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58709272018-04-02 Torulene and torularhodin: “new” fungal carotenoids for industry? Kot, Anna M. Błażejak, Stanisław Gientka, Iwona Kieliszek, Marek Bryś, Joanna Microb Cell Fact Review Torulene and torularhodin represent the group of carotenoids and are synthesized by yeasts and fungi. The most important producers of these two compounds include yeasts of Rhodotorula and Sporobolomyces genera. The first reports confirming the presence of torulene and torularhodin in the cells of microorganisms date to the 1930s and 1940s; however, only in the past few years, the number of works describing the properties of these compounds increased. These compounds have strong anti-oxidative and anti-microbial properties, and thus may be successfully used as food, feedstock, and cosmetics additives. In addition, tests performed on rats and mice showed that both torulene and torularhodin have anti-cancerous properties. In order to commercialize the production of these two carotenoids, it is necessary to obtain highly efficient yeast strains, for example, via mutagenization and optimization of cultivation conditions. Further studies on the activity of torulene and torularhodin on the human body are also needed. BioMed Central 2018-03-27 /pmc/articles/PMC5870927/ /pubmed/29587755 http://dx.doi.org/10.1186/s12934-018-0893-z Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Kot, Anna M. Błażejak, Stanisław Gientka, Iwona Kieliszek, Marek Bryś, Joanna Torulene and torularhodin: “new” fungal carotenoids for industry? |
title | Torulene and torularhodin: “new” fungal carotenoids for industry? |
title_full | Torulene and torularhodin: “new” fungal carotenoids for industry? |
title_fullStr | Torulene and torularhodin: “new” fungal carotenoids for industry? |
title_full_unstemmed | Torulene and torularhodin: “new” fungal carotenoids for industry? |
title_short | Torulene and torularhodin: “new” fungal carotenoids for industry? |
title_sort | torulene and torularhodin: “new” fungal carotenoids for industry? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870927/ https://www.ncbi.nlm.nih.gov/pubmed/29587755 http://dx.doi.org/10.1186/s12934-018-0893-z |
work_keys_str_mv | AT kotannam toruleneandtorularhodinnewfungalcarotenoidsforindustry AT błazejakstanisław toruleneandtorularhodinnewfungalcarotenoidsforindustry AT gientkaiwona toruleneandtorularhodinnewfungalcarotenoidsforindustry AT kieliszekmarek toruleneandtorularhodinnewfungalcarotenoidsforindustry AT brysjoanna toruleneandtorularhodinnewfungalcarotenoidsforindustry |